NUBLOX Trademark

Trademark Overview

On Tuesday, May 10, 2011, a trademark application was filed for NUBLOX with the United States Patent and Trademark Office. The USPTO has given the NUBLOX trademark a serial number of 85316607. The federal status of this trademark filing is ABANDONED - EXPRESS AFTER PUB as of Tuesday, September 20, 2011. This trademark is owned by Novartis AG. The NUBLOX trademark is filed in the Pharmaceutical Products category with the following description:

Anti-infectives; Anti-inflammatories; Antibiotics; Antifungal preparations; Antivirals; Cardiovascular pharmaceuticals; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for the treatment and prevention of disorders of the metabolic system, the musculo-skeletal system, the genitourinary system and for the treatment of inflammatory disorders; pharmaceutical preparations for use in oncology and hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of gastroenterological disorders; Pharmaceutical products for ophthalmological use; Pharma...
nublox

General Information

Serial Number85316607
Word MarkNUBLOX
Filing DateTuesday, May 10, 2011
Status605 - ABANDONED - EXPRESS AFTER PUB
Status DateTuesday, September 20, 2011
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 20, 2011

Trademark Statements

Goods and ServicesAnti-infectives; Anti-inflammatories; Antibiotics; Antifungal preparations; Antivirals; Cardiovascular pharmaceuticals; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for the treatment and prevention of disorders of the metabolic system, the musculo-skeletal system, the genitourinary system and for the treatment of inflammatory disorders; pharmaceutical preparations for use in oncology and hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of gastroenterological disorders; Pharmaceutical products for ophthalmological use; Pharmaceutical products for treating respiratory diseases
Pseudo MarkNEW BLOCKS

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code8 - Abandoned
Class Status DateTuesday, September 20, 2011
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBasel
CH
Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBasel
CH

Trademark Events

Event DateEvent Description
Tuesday, September 20, 2011ABANDONMENT NOTICE MAILED - AFTER PUBLICATION
Tuesday, September 20, 2011ABANDONMENT - AFTER PUBLICATION
Tuesday, September 20, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 20, 2011PUBLISHED FOR OPPOSITION
Friday, September 9, 2011TEAS EXPRESS ABANDONMENT RECEIVED
Monday, August 15, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 10, 2011ASSIGNED TO EXAMINER
Tuesday, May 17, 2011NOTICE OF PSEUDO MARK MAILED
Monday, May 16, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, May 13, 2011NEW APPLICATION ENTERED IN TRAM

Related Keywords

nublox preparations pharmaceutical disorders system treatment diseases prevention anti genitourinary skeletal